2m 2m 2m 2m 2m 2m 2m
BICARA THERAP (BCAX)
NASDAQ
$25.01+$0.45 (+1.85%)
Price as of Jun 23, 2026 4:10 PM EDT- $1.6BMarket Cap
- 167.43%1-Year Change
- BiotechnologyIndustry
BICARA THERAP (BCAX)
$25.01+$0.45 (+1.85%)
BCAX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $24.55 | ||
Change | +$1.32 (+5.68%) | ||
Open | $23.52 | ||
High | $24.60 | ||
Low | $23.28 | ||
Previous Close | $23.23 | ||
Volume | 831,569 | ||
30-Day Average Volume | 600,656 | ||
1-Week Change | 13.87% | ||
1-Month Change | 13.24% | ||
1-Year Change | 167.43% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 65.7M | ||
Total Assets | $553.6M | ||
Market Cap | $1.6B | ||
Enterprise Value | $1.3B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$56.2M | ||
Free Cash Flow | -$37.6M | ||
EBIT | -$56.2M | ||
EBITDA | -$56.1M | ||
Net Working Capital | $505.6M | ||
EPS | -$0.93 | ||
Enterprise Value/EBITDA | -23 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -26 | ||
PEG | 0 | ||
Price/Free Cash Flow | -43 | ||
Price/Operating Cash Flow | -43 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue